Zauber N P, Sabbath-Solitare M, Marotta S P, Zauber A G, Bishop D T
Department of Medicine, Saint Barnabas Medical Center, Livingston, NJ, USA.
J Pathol. 2001 Mar;193(3):303-9. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH813>3.0.CO;2-T.
The purpose of this study was to compare the molecular genetic changes in the Ki-ras and adenomatous polyposis coli (APC) genes between adenomas and carcinomas removed from the same patients. This comparison of benign and malignant tissue would enhance understanding of the progression of molecular changes during the development of colorectal malignancy and similarities between paired lesions could be indicative of a common aetiology. The basic procedures used were DNA extraction from wax blocks of removed tissue, followed by polymerase chain reaction (PCR) and gel electrophoresis for mutations in the Ki-ras gene using single strand conformational polymorphism (SSCP); amplification of a CA repeat marker was used to assess for loss of heterozygosity (LOH) of the APC gene. The main findings in 100 adenoma and carcinoma pairs for the Ki-ras gene were as follows: the frequency of Ki-ras mutation in the adenomas increased with increasing villous component, but did not vary in the paired carcinomas; the frequency of Ki-ras mutation in villous adenomas was greater than in carcinomas; and when both paired lesions had Ki-ras mutations, only 44% had the identical mutation. For the APC gene, the incidence of LOH in the adenomas did not vary by histological type; the LOH status of the adenoma was associated with that of the paired carcinoma; but when both paired lesions had LOH of the APC gene, only 50% had LOH for the same allele. In conclusion, these data on paired adenomas and carcinomas suggest that a Ki-ras mutation is not a consistent finding between the adenoma and carcinoma from the same bowel. The development of LOH of the APC gene is a slightly more consistent finding between the pair, but is not always allelic-specific.
本研究的目的是比较同一患者切除的腺瘤和癌组织中Ki-ras基因及腺瘤性息肉病基因(APC)的分子遗传学变化。对良性和恶性组织进行这种比较,将有助于加深对结直肠癌发生过程中分子变化进展的理解,并且配对病变之间的相似性可能表明存在共同的病因。所采用的基本步骤是从切除组织的蜡块中提取DNA,随后进行聚合酶链反应(PCR),并使用单链构象多态性(SSCP)对Ki-ras基因的突变进行凝胶电泳分析;利用CA重复标记的扩增来评估APC基因的杂合性缺失(LOH)。在100对腺瘤和癌组织中关于Ki-ras基因的主要发现如下:腺瘤中Ki-ras突变的频率随绒毛成分增加而升高,但在配对的癌组织中无变化;绒毛状腺瘤中Ki-ras突变的频率高于癌组织;当配对的病变均有Ki-ras突变时,只有44%具有相同的突变。对于APC基因,腺瘤中LOH的发生率在不同组织学类型中无差异;腺瘤的LOH状态与配对癌组织的LOH状态相关;但当配对的病变均存在APC基因的LOH时,只有50%的等位基因发生LOH。总之,这些关于配对腺瘤和癌组织的数据表明,同一肠道来源的腺瘤和癌组织中Ki-ras突变并非一致的发现。APC基因LOH的发生在配对组织之间稍微更具一致性,但并不总是等位基因特异性的。